South Korea’s financial regulators have officially introduced retail investment limits and capital requirements as part of the legal framework for tokenized securities, set to fully launch by 2027. Under these rules, individual investors will face specific caps on their total exposure to security tokens to mitigate high-volatility risks, while issuers must meet strict minimum capital thresholds to ensure corporate solvency. This regulatory milestone transitions the South Korean security token offering (STO) market from a regulatory sandbox phase into a formal, institutionalized pillar of the national financial system.
The Financial Services Commission (FSC) specified that companies seeking to operate in this space must now obtain a new class of Over-the-Counter (OTC) trading licenses. This move is designed to facilitate the trading of fractionalized Real World Assets (RWAs)—such as real estate, fine art, and intellectual property—outside of traditional stock exchanges. By creating a licensed OTC tier, the government aims to foster a competitive environment for fintech startups and traditional brokerages while maintaining rigorous oversight and consumer protection standards.
This development follows extensive legislative debate in Seoul regarding the classification of digital assets. By clarifying the rules for "investment contract securities" in tokenized form, South Korea is positioning itself as a global leader in the RWA space. The 2026 regulatory update provides the final technical and legal clarity needed for South Korean banks and investment firms to build out the high-frequency infrastructure required to meet the 2027 implementation deadline.
For the global crypto market, South Korea's move signals a major shift toward the institutional adoption of blockchain technology for traditional finance. While the strict investment limits may initially dampen retail speculation, they provide a long-term blueprint for how other major jurisdictions might regulate the fractionalization of high-value assets. Market participants should watch for the first wave of OTC license approvals in late 2026, which will indicate which major financial institutions are poised to dominate the market at launch.